News & Media

The 3rd edition of the RE(ACT) Congress – International Congress on Research of Rare and Orphan Diseases will be held from 9th to 12th March 2016 at the Crowne Plaza Barcelona – Fira Center in Barcelona, Spain. This congress is jointly organized by the Blackswan Foundation and E-Rare. Preferential...
The eighth E-Rare joint call for funding multilateral research projects on rare diseases (JTC2016) on ‘Clinical research for new therapeutic uses of already existing molecules (repurposing) in rare diseases’ was launched on the 7th of December, 2015. The following 15 countries participate in this...
EATRIS ERIC, the European Infrastructure for Translational Medicine, specialises in advancing medicines safely into clinical development. With over 75 leading academic translational research institutions across Europe, EATRIS can find your partner with specialised facilities and long-standing...
A Partner for Multinational Trial ManagementManaging a multinational clinical trial raises multiple challenges for investigators and sponsors. ECRIN, a non-profit research infrastructure, helps organisations to facilitate trials by coordinating various management tasks (regulatory and ethical...
The eighth E-Rare joint call for funding multilateral research projects on rare diseases (JTC2016) will be open on the 7th of December, 2015. The following 14 countries intend to participate in this call: Austria, Canada (including Quebec), France, Germany, Hungary, Israel, Italy, Latvia, Poland,...
In collaboration with EMA, E-Rare will organize a workshop dedicated to Interactions between EMA and RD researchers on pre-licensing activities. The workshop will take place from 09:00 to 16:00 on the 9 of March 2016 in Barcelona, before the official start of the RE(ACT) meeting. It will be open...
In order to access to clinical compounds, pharmaceutical companies like AstraZeneca or Pfizer, are developping programs to propose number of their molecules that could be used in repurposing studies. AstraZeneca Open innovation Program In addition to marketed and Ph 3 compounds listed on the...
It is a pleasure to announce the 3rd international congress on research of rare and orphan diseases to be held at the Crowne Plaza Barcelona – Fira Center in Barcelona, Spain, from 9th to 12th March 2016 a superb setting for stimulating learning, exchanges and networking. This congress is jointly...
It is a pleasure to announce the 3rd international congress on research of rare and orphan diseases to be held at the Crowne Plaza Barcelona – Fira Center in Barcelona, Spain, from 9th to 12th March 2016 a superb setting for stimulating learning, exchanges and networking. This congress is jointly...
On the 15th of December 2014 the following 17 countries:  Austria, Belgium, Canada (including Québec), France, Germany, Greece, Hungary, Israel, Italy, Latvia, Poland, Portugal, Romania, Spain, Switzerland, The Netherlands and Turkey opened the seventh E-Rare joint call (JTC 2015) for funding...

Pages

E-Rare 2012 - Created by Toussaint Biger